Coagulation hemostasis analyzer market – forecast to 2019

MD 3255 | 2014

Medical Devices

Coagulation/Hemostasis Analyzer Market

by Product (Automated, POC), Consumables (Reagents, Standards), Test Type (APTT, Prothrombin Time/INR, D-Dimer, Fibrinogen), Technology (Mechanical, Optical), End Users (Research Institutes, Hospitals)

Forecast to 2019 Report Description

Table of Contents List of Tables Sample Tables Related Reports

MarketsandMarkets North - Dominion Plaza, 17304, Preston Road, Suite 800, Dallas, TX 75252, U.S. Tel. No.: 1-888-600-6441 Email: sales@marketsandmarkets.com Website: www.marketsandmarkets.com

Coagulation/Hemostasis Analyzer Market – Forecast to 2019

MD 3255

MarketsandMarkets is a global market research and consulting company based in the U.S. We publish strategically analyzed market research reports and serve as a business intelligence partner to Fortune 500 companies across the world. MarketsandMarkets also provides multi-client reports, company profiles, databases, and custom research services.

MarketsandMarkets covers fourteen industry verticals, including aerospace and defence, advanced materials, automotives and transportation, banking and financial services, biotechnology, chemicals, consumer goods, energy and power, food and beverages, industrial automation, medical devices, pharmaceuticals, semiconductor and electronics, and telecommunications and IT.

Copyright Š 2014 MarketsandMarkets All Rights Reserved. This document contains highly confidential information and is the sole property of MarketsandMarkets. No part of it may be circulated, copied, quoted, or otherwise reproduced without the approval of MarketsandMarkets.

1 Š MarketsandMarkets

Coagulation/Hemostasis Analyzer Market – Forecast to 2019

1

INTRODUCTION

1.1

OBJECTIVES OF THE STUDY

1.2

MD 3255



To define, describe, and forecast the global coagulation analyzers market on the basis of product, test, technology, end user, and region



To provide detailed information regarding major factors influencing the growth of the market (drivers, restraints, opportunities, and industry-specific challenges)



To strategically analyze micromarkets1 with respect to individual growth trends, future prospects, and contributions to the overall market



To analyze the opportunities in the market for stakeholders and provide details of the competitive landscape for market leaders



To forecast the size of the global coagulation analyzers market with respect to four main regions (along with countries), namely, North America, Europe, Asia-Pacific, and Rest of the World



To strategically profile key players in the global coagulation analyzers market and comprehensively analyze their core competencies2 and market shares



To track and analyze competitive developments such as agreements, partnerships, and alliances; acquisitions; new product developments; expansions; and R&D activities in the global coagulation analyzers market

MARKET DEFINITION

Coagulation analyzers and reagents are used to evaluate the coagulation profiles of blood samples, which are utilized for clotting-based or chromogenic assays and for diagnosing clotting factor deficiencies. Thus, they are primarily used in wound, injury, and post-operative management.

1. Micromarkets are defined as further segments and subsegments of the global coagulation analyzers market included in the report.

2. Core competencies of the companies are captured in terms of their key developments, SWOT analyses, and key strategies adopted to sustain their positions in the market.

2 © MarketsandMarkets

Coagulation/Hemostasis Analyzer Market – Forecast to 2019

1.3

MD 3255

MARKET SCOPE

1.3.1

MARKETS COVERED

This research report divides the coagulation analyzers market into the following segments:

FIGURE 1

COAGULATION ANALYZERS MARKET, BY PRODUCT

COAGULATION ANALYZERS MARKET, BY PRODUCT

Clinical Laboratory Analyzers

Point-of-Care Testing Analyzers

Instruments Automated Analyzers Semi-automated and Manual Analyzers

Consumables Reagents Standards, Calibrators and Controls

Global Hemostasis/Coagulation Analyzers Market, by Product 

Clinical Laboratory Analyzers 





Instruments 

Automated Analyzers



Semi-automated and Manual Analyzers

Consumables 

Reagents



Standards, Calibrations and Controls

Point-of-Care Testing Analyzers

Global Hemostasis/Coagulation Analyzers Market, by Test 

Activated Partial Thromboplastin Time (APTT)



Prothrombin Time (PT/INR)



D-Dimer



Fibrinogen



Others

3 © MarketsandMarkets

Coagulation/Hemostasis Analyzer Market – Forecast to 2019

MD 3255

Global Hemostasis/Coagulation Analyzers Market, by Technology 

Mechanical



Optical



Electrochemical



Others

Global Hemostasis/Coagulation Analyzers Market, by End User 

Research Institutes



Diagnostic laboratories



Standalone Hospitals



Others

Global Hemostasis/Coagulation Analyzers Market, by Region 







North America 

U.S.



Canada

Europe 

Germany



France



U.K.



Italy



Spain



Rest of Europe

Asia-Pacific 

China



Japan



India



Rest of Asia-Pacific

Rest of the World

4 © MarketsandMarkets

Coagulation/Hemostasis Analyzer Market – Forecast to 2019

1.3.2

YEARS CONSIDERED FOR THE STUDY

PARAMETER

SCOPE

2013

Base Year

2012

Historical Year

2014–2019

Forecast Period

2013

Base Year Used for Company Profiles

1.4

MD 3255

CURRENCY

The currency used in this report is USD ($), with market size indicated in $million. 

For companies reporting their revenue in USD, revenues were picked from their annual reports



For companies that reported their revenues in other currencies, the average annual currency conversion rate was used for the particular year to convert the value to USD

1.5

LIMITATIONS



The report does not cover country-level quantitative information (value market) for the RoW market due to the availability of limited information from primary and secondary sources.

However, the report provides country-level qualitative information



The volume market is not included in the report due to limited information available from secondary as well as primary sources

1.6

STAKEHOLDERS



Coagulation Product Manufacturers and Suppliers



Hospitals



Clinical Testing Laboratories



Research and Development (R&D) Companies



Business Research and Consulting Service Providers



Medical Research Laboratories



Academic Medical Centers and Universities

5 © MarketsandMarkets

Coagulation/Hemostasis Analyzer Market – Forecast to 2019

2

RESEARCH METHODOLOGY

2.1

RESEARCH DATA

MD 3255

This research study involved the usage of extensive secondary sources; directories; databases such as Hoovers, Bloomberg Businessweek, Factiva, and OneSource; white papers; annual reports; company house documents; and SEC filings of companies. Secondary research was mainly used to identify and collect information useful for an extensive, technical, market-oriented, and commercial study of the global coagulation analyzers market. It was also used to obtain key information about major players, market classification and segmentation according to the industry trends, regional markets, and developments related to the market and technology perspectives. Primary sources involved in this research study are industry experts from the core and related industries; preferred suppliers, manufacturers, distributors, service providers, technology developers, researchers, and laboratory technicians; and organizations related to all segments of this industry’s value chain. In-depth interviews were conducted from various primary respondents, including key industry participants, subject-matter experts (SMEs), C-level executives of key market players, and industry consultants to obtain and verify critical qualitative and quantitative information as well as to assess future growth prospects. The following figure shows the market research methodology applied in making this report.

FIGURE 2

RESEARCH DESIGN

HISTORICAL DATA FOR THE COAGULATION ANALYZERS MARKET

Market Share Analysis

Regulatory Landscape

Competitive Landscape

Evolution

Company Revenues and R&D Expenses

Regional Usage Pattern

MARKET DRIVERS: • Increasing prevalence of diseases and the number of surgical procedures

INFLUENCING FACTORS (Market Trends and Dynamics)

• Increasing adoption of automated coagulation instruments by diagnostic laboratories • Development of high-sensitivity point-of-care (POC) coagulation testing • Technological advancement and new product launches

MARKET RESTRAINTS:

• Slow adoption of advanced coagulation instruments in emerging economies • High cost of fully automated coagulation analyzers

• Increasing aging population

MARKET OPPORTUNITIES:

CHALLENGE:

• Rapid growth of coagulation market in emerging countries such as India, China, and Brazil

• Stringent and timeconsuming regulatory policies

• Increasing number of hemophilic patients

Historical Data of the Market

Market Size & Forecast, by Product, by Test, and Technology

Impact Analysis of Market Trends

Market Size & Forecast, by End User

FORECAST

Arrive at the Market Size, Share and CAGR for the Coagulation Analyzers Market

6 © MarketsandMarkets

Coagulation/Hemostasis Analyzer Market – Forecast to 2019

MD 3255

In the secondary research process, various secondary sources were referred to for identifying and collecting information useful for this study. These secondary sources include annual reports, press releases, investor presentations of companies, white papers, medical device journals, certified publications, articles from recognized authors, gold standard and silver standard websites, directories, and databases.

Secondary research was mainly used to obtain key information about the industry‘s supply chain, leading and emerging players, market classification and segmentation according to industry trends to the bottommost level, geographical markets, and key developments from both market and technology-oriented perspectives.

In the primary research process, various primary sources from both the supply and demand sides were interviewed to obtain qualitative and quantitative information for this report. Primary sources from the supply-side include industry experts, such as CEOs, vice-presidents, marketing directors, technology and innovation directors; and related key executives from key companies and organizations operating in the market. Primary sources from the demand-side include coagulation analyzers manufacturers, R&D professionals, and technicians.

After complete market engineering (which includes calculations for market statistics, market breakdown, market size estimations, market forecasting, and data triangulation), extensive primary research was conducted to gather information and to verify and validate the critical numbers arrived at. Primary research was also conducted to identify and study segmentation types; industry trends; Porter’s analysis; key players; competitive landscape for the coagulation analyzers market, and the end-products supplied by different market players; and key market dynamics such as drivers, restraints, opportunities, and key player strategies.

In the complete market engineering process, both top-down and bottom-up approaches were extensively used along with several data triangulation methods to perform market estimation and market forecasting for the overall market segments and subsegments listed in this report. Extensive qualitative and quantitative analysis was performed on the complete market engineering process to list key information/insights throughout the report.

2.2

MARKET SIZE ESTIMATION

Top-down and bottom-up approaches were used to estimate and validate the size of the global market and various other dependent submarkets. Key players in this market were identified through secondary research and their market shares in respective geographies determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares, splits, and breakdowns were determined by using secondary sources and verified through primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data. This data was consolidated and added with detailed inputs and analysis from MarketsandMarkets and presented in this report.

The following figure shows an illustrative representation of the overall market size estimation process employed for the purpose of this study.

7 © MarketsandMarkets

Coagulation/Hemostasis Analyzer Market – Forecast to 2019

FIGURE 3

MD 3255

TOP-DOWN APPROACH Top-down Approach

Global Coagulation Analyzers Market ($Million)

Global Coagulation Analyzers Market

Global Market Size is Validated Through Primaries (Demand and Supply Side Experts)

Percentage Split for the Segments of the Coagulation Analyzers Market

Regional Split

Regional and Country-wise Market for Each Segment

FIGURE 4

PRIMARY: Demand and Supply Side Experts

SECONDARY: Annual Reports, Presentations, Press Release, Journals, Paid Databases, Company Websites, News Articles, and MarketsandMarkets Repository

BOTTOM-UP APPROACH Bottom-up Approach

Global Coagulation Analyzers Market

Global Coagulation Analyzers Market

Shares of Company Revenues in the Overall Market

Company-wise Revenue

PRIMARY: Demand and Supply Side Experts SECONDARY: Annual Reports, Presentations, Press Release, Journals, Paid Databases, and MarketsandMarkets Repository

8 © MarketsandMarkets

Coagulation/Hemostasis Analyzer Market – Forecast to 2019

MD 3255

The bottom-up procedure was adopted to arrive at the overall market size of the global coagulation analyzers market from the revenue of key players (companies) and their shares in the market and annual sales of coagulation analyzers, based on the type of product.

Calculations based on the revenue of key companies and sales of coagulation analyzers identified in the market led to the overall market size. This overall market size was used in the top-down procedure to estimate the size of other individual markets through percentage splits from secondary and primary research.

For the calculation of each type of specific market segment, the most appropriate immediate parent market size was used for implementing the top-down procedure. The bottom-up procedure was also implemented to validate market segment revenues obtained from data extracted from secondary research.

Market shares were then estimated for each company to verify revenue shares used earlier in the bottomup procedure. With the data triangulation procedure and the validation of data through primaries, the exact values of the overall parent market size and each individual market size were determined and confirmed in this study. The data triangulation procedure implemented for this study is explained in the next section.

FIGURE 5

BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND REGION NUMBER OF PRIMARIES:

BY COMPANY TYPE

NUMBER OF PRIMARIES:

BY DESIGNATION

NUMBER OF PRIMARIES:

BY REGION

XX XX XX

XX

XX

XX XX

XX

Tier 1 Companies Tier 3 Companies

XX Tier 2 Companies

C-Level

Director-Level

XX

Others

North America

Europe

Asia-Pacific

RoW

Note: *Others include sales managers, marketing managers, and product managers Company tiers are defined on the basis of their total revenue, as of 2013; Tier 1 = > $XX Billion, Tier 2 = $XX Million-$XX Billion, and Tier 3 = < $XX Million

9 Š MarketsandMarkets

Coagulation/Hemostasis Analyzer Market – Forecast to 2019

2.3

MD 3255

MARKET BREAKDOWN AND DATA TRIANGULATION

After arriving at the overall market size from the market size estimation process explained above, the total market was split into several segments and subsegments. In order to complete the overall market engineering process and arrive at the exact statistics for all the segments and subsegments, data triangulation and market breakdown procedures were employed wherever applicable. Data was triangulated by studying various factors and trends from both the demand and supply sides. Along with this, the market was validated using both top-down and bottom-up approaches.

FIGURE 6

DATA TRIANGULATION METHODOLOGY PRIMARY SOURCES

SECONDARY SOURCES

DEMAND SIDE

Interviews with: • Chief Information Officers

• Technicians, Technologists, Physicians, and Nurses • Purchase Managers in Healthcare Provider Organizations

Annual Reports, Investor Presentations, Websites and Press Releases of Top Players, News Articles, Journals, and Paid Databases

• •

World Health Organization (WHO) Centers for Disease Control and Prevention (CDC) National Institutes of Health (NIH)

MnM KNOW*

Interviews with: • CEOs and Vice-presidents

SUPPLY SIDE

•

PRIMARY SOURCE

• Marketing Directors

DATA TRIANGULATION SECONDARY SOURCE

• Technology and Innovation Directors and Related Key Executives From Various Key Companies and Organizations Operating in the Coagulation Analyzers Market

•

INFORMATION SOURCED

Key Players

Competitive Landscape

Drivers/Restraints

Opportunities/Challenges

Forecasting

Market Size (2014) and Market Share (2014)

Region-wise Analysis

MnM KNOW* stands for MarketsandMarkets’ 'Knowledge Asset Management' framework. In this context, it stands for an existing market research knowledge repository of over 5,000 granular markets, our flagship competitive intelligence and market research platform "RT", subject matter experts, and independent consultants. MnM KNOW acts as an independent source that helps us validate information gathered from primary and secondary sources .

Note: MnM KNOW* stands for ‘MarketsandMarkets Knowledge Asset Management' framework. In this context, it stands for existing market research knowledge repository of over 5,000 granular markets, our flagship competitive intelligence and market research platform "RT", subject matter experts, and independent consultants. MnM KNOW acts as an independent source that helps us validate information gathered from primary and secondary sources.

10 © MarketsandMarkets

Coagulation/Hemostasis Analyzer Market – Forecast to 2019

2.4

MD 3255

MARKET SHARE ESTIMATION

The market shares for key players have been calculated based on secondary data available through paid and unpaid sources and by analyzing the product portfolios of the top companies. This data was further validated through expert interviews.

2.5

KEY DATA FROM SECONDARY SOURCES SECONDARY SOURCES

DATA

Market Size

• • • • • •

Company Financials Magazines Journals Press Releases Paid Databases MarketsandMarkets Data Repository

Revenue of Companies

• • • •

Annual Reports Company Websites Public Databases MarketsandMarkets Data Repository

Qualitative Information (Market Dynamics and Trends)

• • • •

Company Websites Annual Reports Press Releases MarketsandMarkets Data Repository

11 © MarketsandMarkets

Coagulation/Hemostasis Analyzer Market – Forecast to 2019

2.6

MD 3255

KEY DATA FROM PRIMARY SOURCES

TYPES

Regional Split

Global Market Size

PARAMETERS •

Overall market and segments in 2014

•

CAGR of each region in the forecast period (2014–2019)

•

Global market size for 2014

•

CAGR for the forecast period (2014–2019)

•

Clinical Laboratory Analyzers and Pointof-Care Testing Analyzers

•

Activated Partial Thromboplastin Time (APTT), Prothrombin Time (PT/INR), DDimer, Fibrinogen, Others

Market Split •

•

Mechanical, Optical, Electrochemical, and Others Standalone Hospitals, Diagnostic Laboratories, Research Institutes, and other end users

DATA  Global coagulation analyzers market, by region–North America, Europe, Asia, and RoW

 Global coagulation analyzers market  Coagulation analyzers market, by segment  Coagulation analyzers market, by product, test, technology, and end user

 Coagulation analyzers market, by product  Coagulation analyzers market, by type of test  Coagulation analyzers market, by technology  Coagulation analyzers market, by end user

12 © MarketsandMarkets

Coagulation/Hemostasis Analyzer Market – Forecast to 2019

2.7

MD 3255

KEY INDUSTRY INSIGHTS

“Consumables will be a major market in the global clinical laboratory analyzers market.”

– President and CEO,

“The average growth rate for the global coagulation analyzers market will be around XX% to XX%.”

Leading Company

– CEO, Leading Coagulation Analyzers Company

“The market for point-of-care testing coagulation analyzers is currently smaller as compared that of Clinical Laboratory Analyzers ; however, this market is expected to grow at a higher rate in the next five years due to technological advancements and investments by companies.”

– Sales Director, Leading

“Emerging markets such as India and China are new avenues for growth of the coagulation analyzers market due to the major interest of companies in these regions.”

–CEO, Leading Coagulation Analyzers Company

Coagulation Analyzers Manufacturing Company

2.8

ASSUMPTIONS FOR THE STUDY

The following assumptions were taken into consideration to complete the overall market engineering of the coagulation analyzers market:

PARAMETERS

Market Growth

ASSUMPTIONS The CAGR for the forecast period is assumed to be normalized and the effect of inflation, recession, economic downturn, regulatory or policy changes, or other factors are not considered.

13 © MarketsandMarkets

Coagulation/Hemostasis Analyzer Market – Forecast to 2019

MD 3255

TABLE OF CONTENTS 1

2

3

INTRODUCTION ........................................................................................................ 18 1.1

OBJECTIVES OF THE STUDY ...........................................................................................................18

1.2

MARKET DEFINITION .....................................................................................................................18

1.3

MARKET SCOPE............................................................................................................................18

5

MARKETS COVERED ....................................................................................................... 18

1.3.2

YEARS CONSIDERED FOR THE STUDY .............................................................................. 20

1.4

CURRENCY ...................................................................................................................................21

1.5

LIMITATIONS ................................................................................................................................21

1.6

STAKEHOLDERS ...........................................................................................................................21

RESEARCH METHODOLOGY ...................................................................................... 22 2.1

RESEARCH DATA ..........................................................................................................................22

2.2

MARKET SIZE ESTIMATION ............................................................................................................23

2.3

MARKET BREAKDOWN AND DATA TRIANGULATION ........................................................................25

2.4

MARKET SHARE ESTIMATION ........................................................................................................27

2.5

KEY DATA FROM SECONDARY SOURCES .......................................................................................27

2.6

KEY DATA FROM PRIMARY SOURCES ............................................................................................28

2.7

KEY INDUSTRY INSIGHTS ..............................................................................................................28

2.8

ASSUMPTIONS FOR THE STUDY ....................................................................................................29

EXECUTIVE SUMMARY .............................................................................................. 30 3.1

4

1.3.1

INTRODUCTION ............................................................................................................................30

PREMIUM INSIGHTS ................................................................................................ 35 4.1

HIGH GROWTH POTENTIAL OF THE COAGULATION ANALYZERS MARKET..........................................35

4.2

GLOBAL CLINICAL LABORATORY ANALYZERS, BY TYPE ...................................................................36

4.3

GLOBAL COAGULATION ANALYZERS MARKET, BY REGION..............................................................37

4.4

COAGULATION ANALYZERS MARKET, BY INSTRUMENT...................................................................38

4.5

COAGULATION ANALYZERS MARKET, BY TEST ................................................................................39

4.6

GLOBAL COAGULATION ANALYZERS MARKET, BY END USER ..........................................................40

4.7

LIFECYCLE ANALYSIS, BY REGION .................................................................................................41

MARKET OVERVIEW.................................................................................................. 42 5.1

INTRODUCTION ............................................................................................................................43

5.2

MARKET SEGMENTATION ..............................................................................................................43 5.2.1

COAGULATION ANALYZERS MARKET, BY PRODUCT.......................................................... 43

5.2.2

COAGULATION ANALYZERS MARKET, BY TEST ................................................................. 43

5.2.3

COAGULATION ANALYZERS MARKET, BY TECHNOLOGY .................................................... 44

5.2.4

COAGULATION ANALYZERS MARKET, BY END USER ......................................................... 45 14

© MarketsandMarkets

Coagulation/Hemostasis Analyzer Market – Forecast to 2019

5.2.5

MARKET DYNAMICS......................................................................................................................46

5.4

DRIVERS ......................................................................................................................................47

5.6

5.7

5.4.1

INCREASING PREVALENCE OF DISEASES AND RISING NUMBER OF SURGICAL PROCEDURES ................................................................................................................ 47

5.4.2

INCREASING ADOPTION OF AUTOMATED COAGULATION INSTRUMENTS BY DIAGNOSTIC LABORATORIES .......................................................................................... 48

5.4.3

DEVELOPMENT OF HIGH-SENSITIVITY POINT-OF-CARE (POC) COAGULATION TESTING ......................................................................................................................... 48

5.4.4

GROWTH IN AGING POPULATION..................................................................................... 48

5.4.5

TECHNOLOGICAL ADVANCEMENTS AND NEW PRODUCT LAUNCHES ................................ 49

RESTRAINTS .................................................................................................................................50 5.5.1

SLOW ADOPTION OF ADVANCED COAGULATION INSTRUMENTS IN EMERGING ECONOMIES................................................................................................................... 50

5.5.2

HIGH COST OF FULLY AUTOMATED COAGULATION ANALYZERS ........................................ 50

OPPORTUNITIES ...........................................................................................................................51 5.6.1

RAPID GROWTH IN THE COAGULATION MARKET IN EMERGING ECONOMIES..................... 51

5.6.2

INCREASING NUMBER OF HEMOPHILIC PATIENTS........................................................... 51

CHALLENGE .................................................................................................................................52 5.7.1

7

8

COAGULATION ANALYZERS MARKET, BY REGION ............................................................ 45

5.3

5.5

6

MD 3255

STRINGENT AND TIME-CONSUMING REGULATORY POLICIES ........................................... 52

INDUSTRY INSIGHTS ............................................................................................... 54 6.1

INTRODUCTION ............................................................................................................................54

6.2

PORTER’S FIVE FORCES ANALYSIS ................................................................................................54 6.2.1

THREAT FROM NEW ENTRANTS ....................................................................................... 55

6.2.2

THREAT FROM SUBSTITUTES .......................................................................................... 56

6.2.3

BARGAINING POWER OF SUPPLIERS .............................................................................. 56

6.2.4

BARGAINING POWER OF BUYERS ................................................................................... 56

6.2.5

INTENSITY OF COMPETITIVE RIVALRY .............................................................................. 57

6.3

SUPPLY CHAIN ANALYSIS .............................................................................................................57

6.4

STRATEGIC BENCHMARKING ........................................................................................................59

HEMOSTASIS/COAGULATION ANALYZERS MARKET, BY TYPE OF TEST ........................ 61 7.1

INTRODUCTION ............................................................................................................................62

7.2

PROTHROMBIN TIME (PT/INR) TEST ..............................................................................................63

7.3

ACTIVATED CLOTTING TIME (ACT/APTT) TEST .................................................................................65

7.4

D-DIMER TEST ..............................................................................................................................68

7.5

FIBRINOGEN TEST ........................................................................................................................70

7.6

OTHERS COAGULATION TEST.........................................................................................................72

COAGULATION ANALYZERS MARKET, BY TYPE ........................................................... 76 8.1

INTRODUCTION ............................................................................................................................77

8.2

CLINICAL LABORATORY COAGULATION ANALYZERS .......................................................................78 15

© MarketsandMarkets

Coagulation/Hemostasis Analyzer Market – Forecast to 2019

8.2.1

INSTRUMENTS ............................................................................................................... 81 8.2.1.1

8.2.2

8.3

9

MD 3255

Fully Automated Coagulation Analyzers .............................................................. 85

COAGULATION CONSUMABLES ...................................................................................... 90

POINT-OF-CARE TESTING COAGULATION ANALYZERS ....................................................................97

COAGULATION ANALYZERS MARKET, BY TECHNOLOGY............................................ 101 9.1

INTRODUCTION ..........................................................................................................................102

9.2

PHOTO OPTICAL TECHNOLOGY ....................................................................................................102

9.3

MECHANICAL TECHNOLOGY........................................................................................................103

9.4

ELECTROCHEMICAL TECHNOLOGY ..............................................................................................103

9.5

OTHER TECHNOLOGIES ...............................................................................................................103

10 HEMOSTASIS/COAGULATION ANALYZERS MARKET, BY END USER .......................... 104 10.1

INTRODUCTION ..........................................................................................................................105

10.2

RESEARCH INSTITUTES ...............................................................................................................106

10.3

DIAGNOSTIC LABORATORIES ......................................................................................................109

10.4

STANDALONE HOSPITALS ...........................................................................................................111

10.5

OTHER END USERS .....................................................................................................................113

11 COAGULATION ANALYZERS MARKET, BY REGION .................................................... 117 11.1

INTRODUCTION ..........................................................................................................................118

11.2

NORTH AMERICA ........................................................................................................................121

11.3

11.4

11.5

11.2.1

U.S. .............................................................................................................................127

11.2.2

CANADA.......................................................................................................................131

EUROPE .....................................................................................................................................135 11.3.1

GERMANY ....................................................................................................................139

11.3.2

FRANCE .......................................................................................................................142

11.3.3

U.K. .............................................................................................................................146

11.3.4

ITALY............................................................................................................................149

11.3.5

SPAIN ..........................................................................................................................152

11.3.6

REST OF EUROPE (ROE) ................................................................................................156

ASIA-PACIFIC .............................................................................................................................159 11.4.1

JAPAN ..........................................................................................................................163

11.4.2

CHINA ..........................................................................................................................167

11.4.3

INDIA ...........................................................................................................................170

11.4.4

REST OF ASIA-PACIFIC (ROAPAC) ..................................................................................175

REST OF THE WORLD (ROW) ........................................................................................................178

12 COMPETITIVE LANDSCAPE ..................................................................................... 184 12.1

OVERVIEW ..................................................................................................................................184

12.2

MARKET SHARE ANALYSIS ..........................................................................................................185 12.2.1

MARKET SHARE ANALYSIS FOR CLINICAL LABORATORY ANALYZERS MARKET ................185 16

© MarketsandMarkets

Coagulation/Hemostasis Analyzer Market – Forecast to 2019

12.2.2

12.3

MD 3255

MARKET SHARE ANALYSIS FOR POINT-OF-CARE COAGULATION ANALYZERS MARKET .......................................................................................................................186

COMPETITIVE SITUATION AND TRENDS........................................................................................187 12.3.1

EXPANSIONS................................................................................................................188

12.3.2

NEW PRODUCT LAUNCHES ...........................................................................................189

12.3.3

AGREEMENTS, PARTNERSHIPS, & ALLIANCES ..............................................................190

12.3.4

ACQUISITIONS .............................................................................................................191

12.3.5

OTHER DEVELOPMENTS ...............................................................................................191

13 COMPANY PROFILES .............................................................................................. 193 13.1

INTRODUCTION ..........................................................................................................................193

13.2

SIEMENS HEALTHCARE (A DIVISION OF SIEMENS AG) .................................................................194

13.3

13.4

13.5

13.6

13.7

13.2.1

BUSINESS OVERVIEW...................................................................................................194

13.2.2

SIEMENS AG: COMPANY SNAPSHOT .............................................................................194

13.2.3

PRODUCT PORTFOLIO...................................................................................................195

13.2.4

KEY STRATEGY..............................................................................................................196

13.2.5

RECENT DEVELOPMENTS..............................................................................................196

SYSMEX CORPORATION ..............................................................................................................198 13.3.1

BUSINESS OVERVIEW...................................................................................................198

13.3.2

SYSMEX CORPORATION: COMPANY SNAPSHOT ............................................................198

13.3.3

PRODUCT PORTFOLIO...................................................................................................199

13.3.4

KEY STRATEGIES ..........................................................................................................200

13.3.5

RECENT DEVELOPMENTS..............................................................................................200

ROCHE DIAGNOSTICS (A DIVISION OF F. HOFFMANN-LA ROCHE LTD.) ..........................................202 13.4.1

BUSINESS OVERVIEW...................................................................................................202

13.4.2

ROCHE DIAGNOSTICS: COMPANY SNAPSHOT ...............................................................202

13.4.3

PRODUCT PORTFOLIO...................................................................................................203

13.4.4

KEY STRATEGY..............................................................................................................203

13.4.5

RECENT DEVELOPMENTS..............................................................................................203

NIHON KOHDEN CORPORATION ..................................................................................................205 13.5.1

BUSINESS OVERVIEW...................................................................................................205

13.5.2

NIHON KOHDEN CORPORATION: COMPANY SNAPSHOT.................................................205

13.5.3

PRODUCT PORTFOLIO...................................................................................................206

13.5.4

KEY STRATEGY..............................................................................................................206

13.5.5

RECENT DEVELOPMENTS..............................................................................................206

INTERNATIONAL TECHNIDYNE CORPORATION (ITC) ......................................................................208 13.6.1

BUSINESS OVERVIEW...................................................................................................208

13.6.2

KEY FINANCIALS...........................................................................................................208

13.6.3

PRODUCTS...................................................................................................................208

13.6.4

KEY STRATEGY..............................................................................................................208

13.6.5

RECENT DEVELOPMENTS..............................................................................................208

HELENA LABORATORIES .............................................................................................................209 17

© MarketsandMarkets

Coagulation/Hemostasis Analyzer Market – Forecast to 2019

13.8

13.9

13.10

13.11

MD 3255

13.7.1

BUSINESS OVERVIEW...................................................................................................209

13.7.2

KEY FINANCIALS...........................................................................................................209

13.7.3

PRODUCT PORTFOLIO...................................................................................................209

ALERE, INC. ................................................................................................................................210 13.8.1

BUSINESS OVERVIEW...................................................................................................210

13.8.2

ALERE, INC.: COMPANY SNAPSHOT ..............................................................................210

13.8.3

PRODUCT PORTFOLIO...................................................................................................210

13.8.4

KEY STRATEGY..............................................................................................................211

DIAGNOSTICA STAGO SAS ..........................................................................................................211 13.9.1

BUSINESS OVERVIEW...................................................................................................211

13.9.2

KEY FINANCIALS...........................................................................................................211

13.9.3

PRODUCT PORTFOLIO...................................................................................................211

13.9.4

KEY STRATEGY..............................................................................................................211

13.9.5

RECENT DEVELOPMENTS..............................................................................................212

INSTRUMENTATION LABORATORY (A DIVISION OF THE WERFEN GROUP) ......................................212 13.10.1

BUSINESS OVERVIEW...................................................................................................212

13.10.2

KEY FINANCIALS...........................................................................................................213

13.10.3

PRODUCT PORTFOLIO...................................................................................................213

13.10.4

KEY STRATEGY..............................................................................................................213

13.10.5

RECENT DEVELOPMENTS..............................................................................................213

THERMO FISHER SCIENTIFIC, INC. ..............................................................................................214 13.11.1

BUSINESS OVERVIEW...................................................................................................214

13.11.2

THERMO FISHER SCIENTIFIC: COMPANY SNAPSHOT .....................................................215

13.11.3

PRODUCT PORTFOLIO...................................................................................................215

13.11.4

KEY STRATEGIES ..........................................................................................................216

13.11.5

RECENT DEVELOPMENTS..............................................................................................216

14 APPENDIX .............................................................................................................. 217 14.1

INSIGHTS FROM INDUSTRY EXPERTS ..........................................................................................217

14.2

DISCUSSION GUIDE ...................................................................................................................217

14.3

COMPANY DEVELOPMENTS (2012–2014) ..................................................................................221 14.3.1

SYSMEX CORPORATION................................................................................................221

14.3.2

NIHON KOHEDEN CORPORATION ..................................................................................222

14.3.3

SIEMENS HEALTHCARE ................................................................................................222

14.3.4

DIAGNOSTICA STAGO, INC. ...........................................................................................222

14.3.5

INSTRUMENTATION LABORATORY (A DIVISION OF THE WERFEN GROUP) ........................223

14.4

INTRODUCING RT: REAL-TIME MARKET INTELLIGENCE .................................................................223

14.5

AVAILABLE CUSTOMIZATIONS .....................................................................................................224

14.6

RELATED REPORTS .....................................................................................................................224

18 © MarketsandMarkets

Coagulation/Hemostasis Analyzer Market – Forecast to 2019

MD 3255

LIST OF TABLES U

TABLE 1

INCREASING ADOPTION OF AUTOMATED COAGULATION INSTRUMENTS BY DIAGNOSTIC LABORATORIES TO DRIVE THE COAGULATION ANALYZERS MARKET

49

HIGH COST OF FULLY AUTOMATED COAGULATION ANALYZERS RESTRAINING MARKET GROWTH

51

EMERGING MARKETS OFFER SIGNIFICANT POTENTIAL FOR COAGULATION ANALYZERS

52

STRINGENT REGULATORY POLICIES: A MAJOR CHALLENGE IN THE COAGULATION ANALYZERS MARKET

53

TABLE 5

COAGULATION ANALYZERS MARKET SIZE, BY TEST, 2012–2019 ($MILLION)

63

TABLE 6

PROTHROMBIN TIME (PT/INR) TESTING MARKET SIZE, BY REGION, 2012–2019 ($MILLION)

63

NORTH AMERICA: PROTHROMBIN TIME (PT/INR) TESTING MARKET SIZE, BY REGION, 2012–2019 ($MILLION)

64

EUROPE: PROTHROMBIN TIME (PT/INR) TESTING MARKET SIZE, BY REGION, 2012–2019 ($MILLION)

64

APAC: PROTHROMBIN TIME (PT/INR) TESTING MARKET SIZE, BY REGION, 2012– 2019 ($MILLION)

65

ACTIVATED CLOTTING TIME (ACT/APTT) TESTING MARKET SIZE, BY REGION, 2012– 2019 ($MILLION)

66

NORTH AMERICA: ACTIVATED CLOTTING TIME (ACT/APTT) TESTING MARKET SIZE,

BY REGION, 2012–2019 ($MILLION)

66

EUROPE: ACTIVATED CLOTTING TIME (ACT/APTT) TESTING MARKET SIZE, BY REGION, 2012–2019 ($MILLION)

67

APAC: ACTIVATED CLOTTING TIME (ACT/APTT) TESTING MARKET SIZE, BY REGION, 2012–2019 ($MILLION)

67

TABLE 14

D-DIMER TESTING MARKET SIZE, BY REGION, 2012–2019 ($MILLION)

68

TABLE 15

NORTH AMERICA: D-DIMER TESTING MARKET SIZE, BY REGION, 2012–2019 ($MILLION)

68

TABLE 16

EUROPE: D-DIMER TESTING MARKET SIZE, BY REGION, 2012–2019 ($MILLION)

69

TABLE 17

APAC: D-DIMER TESTING MARKET SIZE, BY REGION, 2012–2019 ($MILLION)

69

TABLE 18

FIBRINOGEN TESTING MARKET SIZE, BY REGION, 2012–2019 ($MILLION)

70

TABLE 19

NORTH AMERICA: FIBRINOGEN TESTING MARKET SIZE, BY REGION, 2012–2019 ($MILLION)

70

EUROPE: FIBRINOGEN TESTING MARKET SIZE, BY REGION, 2012–2019 ($MILLION)

71

TABLE 21

APAC: FIBRINOGEN TESTING MARKET SIZE, BY REGION, 2012–2019 ($MILLION)

71

TABLE 22

OTHER TESTS MARKET SIZE, BY REGION, 2012–2019 ($MILLION)

72

TABLE 23

NORTH AMERICA: OTHER TESTS MARKET SIZE, BY REGION, 2012–2019 ($MILLION)

72

TABLE 24

EUROPE: OTHER TESTS MARKET SIZE, BY REGION, 2012–2019 ($MILLION)

73

TABLE 25

APAC: OTHER TESTS MARKET SIZE, BY REGION, 2012–2019 ($MILLION)

73

TABLE 26

COAGULATION ANALYZERS MARKET SIZE, BY PRODUCT, 2012–2019 ($MILLION)

77

TABLE 27

CLINICAL LABORATORY COAGULATION ANALYZERS MARKET SIZE, BY PRODUCT, 2012–2019 ($MILLION)

79

CLINICAL LABORATORY COAGULATION ANALYZERS MARKET SIZE, BY REGION, 2012–2019 ($MILLION)

79

TABLE 2 TABLE 3 TABLE 4

TABLE 7 TABLE 8 TABLE 9 TABLE 10 TABLE 11 TABLE 12 TABLE 13

TABLE 20

TABLE 28

19 © MarketsandMarkets

Coagulation/Hemostasis Analyzer Market – Forecast to 2019

TABLE 29

MD 3255

NORTH AMERICA: CLINICALLABORATORY COAGULATION ANALYZERS MARKET SIZE,

BY COUNTRY, 2012–2019 ($MILLION)

79

EUROPE: CLINICAL LABORATORY COAGULATION ANALYZERS MARKET SIZE, BY COUNTRY, 2012–2019 ($MILLION)

80

APAC: CLINICAL LABORATORY COAGULATION ANALYZERS MARKET SIZE, BY COUNTRY, 2012–2019 ($MILLION)

80

TABLE 32

COAGULATION INSTRUMENTS MARKET SIZE, BY TYPE, 2012–2019 ($MILLION)

82

TABLE 33

COAGULATION INSTRUMENTS MARKET SIZE, BY REGION, 2012–2019 ($MILLION)

83

TABLE 34

NORTH AMERICA: COAGULATION INSTRUMENTS MARKET SIZE, BY COUNTRY, 2012–2019 ($MILLION)

83

EUROPE: COAGULATION INSTRUMENTS MARKET SIZE, BY COUNTRY, 2012–2019 ($MILLION)

84

APAC: COAGULATION INSTRUMENTS MARKET SIZE, BY COUNTRY, 2012–2019 ($MILLION)

84

FULLY AUTOMATED COAGULATION ANALYZERS MARKET SIZE, BY REGION, 2012– 2019 ($MILLION)

85

NORTH AMERICA: FULLY AUTOMATED COAGULATION ANALYZERS MARKET SIZE, BY COUNTRY, 2012–2019 ($MILLION)

86

EUROPE: FULLY AUTOMATED COAGULATION ANALYZERS MARKET SIZE, BY COUNTRY, 2012–2019 ($MILLION)

86

APAC: FULLY AUTOMATED COAGULATION ANALYZERS MARKET SIZE, BY COUNTRY, 2012–2019 ($MILLION)

87

SEMI-AUTOMATED AND MANUAL COAGULATION ANALYZERS MARKET SIZE, BY REGION, 2012–2019 ($MILLION)

88

NORTH AMERICA: SEMI-AUTOMATED AND MANUAL COAGULATION ANALYZERS MARKET SIZE, BY COUNTRY, 2012–2019 ($MILLION)

88

EUROPE: SEMI-AUTOMATED AND MANUAL COAGULATION ANALYZERS MARKET SIZE, BY COUNTRY, 2012–2019 ($MILLION)

89

APAC: SEMI-AUTOMATED AND MANUAL COAGULATION ANALYZERS MARKET SIZE,

BY COUNTRY, 2012–2019 ($MILLION)

89

TABLE 45

COAGULATION CONSUMABLES MARKET SIZE, BY TYPE, 2012–2019 ($MILLION)

90

TABLE 46

COAGULATION CONSUMABLES MARKET SIZE, BY REGION, 2012–2019 ($MILLION)

91

TABLE 47

NORTH AMERICA: COAGULATION CONSUMABLES MARKET SIZE, BY COUNTRY, 2012–2019 ($MILLION)

91

EUROPE: COAGULATION CONSUMABLES MARKET SIZE, BY COUNTRY, 2012–2019 ($MILLION)

91

APAC: COAGULATION CONSUMABLES MARKET SIZE, BY COUNTRY, 2012–2019 ($MILLION)

92

TABLE 50

COAGULATION REAGENTS MARKET SIZE, BY REGION, 2012–2019 ($MILLION)

93

TABLE 51

NORTH AMERICA: COAGULATION REAGENTSMARKET SIZE, BY COUNTRY, 2012– 2019 ($MILLION)

93

EUROPE: COAGULATION REAGENTS MARKET SIZE, BY COUNTRY, 2012–2019 ($MILLION)

94

APAC: COAGULATION REAGENTS MARKET SIZE, BY COUNTRY, 2012–2019 ($MILLION)

94

COAGULATION STANDARDS, CALIBRATORS, AND CONTROLS MARKET SIZE, BY REGION, 2012–2019 ($MILLION)

95

NORTH AMERICA: COAGULATION STANDARDS, CALIBRATORS, AND CONTROLS MARKET SIZE, BY COUNTRY, 2012–2019 ($MILLION)

96

EUROPE: COAGULATION STANDARDS, CALIBRATORS, AND CONTROLS MARKET SIZE, BY COUNTRY, 2012–2019 ($MILLION)

96

TABLE 30 TABLE 31

TABLE 35 TABLE 36 TABLE 37 TABLE 38 TABLE 39 TABLE 40 TABLE 41 TABLE 42 TABLE 43 TABLE 44

TABLE 48 TABLE 49

TABLE 52 TABLE 53 TABLE 54 TABLE 55 TABLE 56

20 © MarketsandMarkets

Coagulation/Hemostasis Analyzer Market – Forecast to 2019

TABLE 57

MD 3255

APAC: COAGULATION STANDARDS, CALIBRATORS, AND CONTROLS MARKET SIZE,

BY COUNTRY, 2012–2019 ($MILLION)

97

POINT-OF-CARE TESTING COAGULATION ANALYZERS MARKET SIZE, BY REGION, 2012–2019 ($MILLION)

98

NORTH AMERICA: POINT-OF-CARE TESTING COAGULATION ANALYZERS MARKET SIZE, BY COUNTRY, 2012–2019 ($MILLION)

99

EUROPE: POINT-OF-CARE TESTING COAGULATION ANALYZERS MARKET SIZE, BY COUNTRY, 2012–2019 ($MILLION)

99

APAC: POINT-OF-CARE TESTING COAGULATION ANALYZERS MARKET SIZE, BY COUNTRY, 2012–2019 ($MILLION)

100

TABLE 62

COAGULATION ANALYZERS MARKET SIZE, BY END USER, 2012–2019 ($MILLION)

105

TABLE 63

COAGULATION ANALYZERS MARKET SIZE FOR RESEARCH INSTITUTES, BY REGION, 2012–2019 ($MILLION)

106

NORTH AMERICA: COAGULATION ANALYZERS MARKET SIZE FOR RESEARCH INSTITUTES, BY COUNTRY, 2012–2019 ($MILLION)

107

EUROPE: COAGULATION ANALYZERS MARKET SIZE FOR RESEARCH INSTITUTES, BY COUNTRY, 2012–2019 ($MILLION)

107

APAC: COAGULATION ANALYZERS MARKET SIZE FOR RESEARCH INSTITUTES, BY COUNTRY, 2012–2019 ($MILLION)

108

COAGULATION ANALYZERS MARKET SIZE FOR DIAGNOSTIC LABORATORIES, BY REGION, 2012–2019 ($MILLION)

109

NORTH AMERICA: COAGULATION ANALYZERS MARKET SIZE FOR DIAGNOSTIC LABORATORIES, BY COUNTRY, 2012–2019 ($MILLION)

109

EUROPE: COAGULATION ANALYZERS MARKET SIZE FOR DIAGNOSTIC LABORATORIES, BY COUNTRY, 2012–2019 ($MILLION)

110

APAC: COAGULATION ANALYZERS MARKET SIZE FOR DIAGNOSTIC LABORATORIES,

BY COUNTRY, 2012–2019 ($MILLION)

110

COAGULATION ANALYZERS MARKET SIZE FOR STANDALONE HOSPITALS, BY REGION, 2012–2019 ($MILLION)

111

NORTH AMERICA: COAGULATION ANALYZERS MARKET SIZE FOR STANDALONE HOSPITALS, BY COUNTRY, 2012–2019 ($MILLION)

112

EUROPE: COAGULATION ANALYZERS MARKET SIZE FOR STANDALONE HOSPITALS,

BY COUNTRY, 2012–2019 ($MILLION)

112

APAC: COAGULATION ANALYZERS MARKET SIZE FOR STANDALONE HOSPITALS, BY COUNTRY, 2012–2019 ($MILLION)

113

COAGULATION ANALYZERS MARKET SIZE FOR OTHERS, BY REGION, 2012–2019 ($MILLION)

114

NORTH AMERICA: COAGULATION ANALYZERS MARKET SIZE FOR OTHERS, BY COUNTRY, 2012–2019 ($MILLION)

115

EUROPE: COAGULATION ANALYZERS MARKET SIZE FOR OTHERS, BY COUNTRY, 2012–2019 ($MILLION)

115

APAC: COAGULATION ANALYZERS MARKET SIZE FOR OTHERS, BY REGION, 2012– 2019 ($MILLION)

116

TABLE 79

COAGULATION ANALYZERS MARKET SIZE, BY REGION, 2012–2019 ($MILLION)

119

TABLE 80

NORTH AMERICA: COAGULATION ANALYZERS MARKET SIZE, BY COUNTRY, 2012– 2019 ($MILLION)

120

EUROPE: COAGULATION ANALYZERS MARKET SIZE, BY COUNTRY, 2012–2019 ($MILLION)

120

APAC: COAGULATION ANALYZERS MARKET SIZE, BY COUNTRY, 2012–2019 ($MILLION)

121

TABLE 58 TABLE 59 TABLE 60 TABLE 61

TABLE 64 TABLE 65 TABLE 66 TABLE 67 TABLE 68 TABLE 69 TABLE 70 TABLE 71 TABLE 72 TABLE 73 TABLE 74 TABLE 75 TABLE 76 TABLE 77 TABLE 78

TABLE 81 TABLE 82

21 © MarketsandMarkets

Coagulation/Hemostasis Analyzer Market – Forecast to 2019

TABLE 83

MD 3255

NORTH AMERICA: COAGULATION ANALYZERS MARKET SIZE, BY PRODUCT, 20122019 ($MILLION)

123

NORTH AMERICA: CLINICAL LABORATORY COAGULATION ANALYZERS MARKET SIZE, BY TYPE, 2012–2019 ($MILLION)

124

NORTH AMERICA: COAGULATION INSTRUMENTS MARKET SIZE, BY TYPE, 2012– 2019 ($MILLION)

124

TABLE 86

NORTH AMERICA: CONSUMABLES MARKET SIZE, BY TYPE, 2012–2019 ($MILLION)

125

TABLE 87

NORTH AMERICA: COAGULATION ANALYZERS MARKET SIZE, BY TYPE OF TEST, 2012-2019 ($MILLION)

125

NORTH AMERICA: COAGULATION ANALYZERS MARKET SIZE, BY END USER, 20122019 ($MILLION)

126

U.S.: COAGULATION ANALYZERS MARKET SIZE, BY PRODUCT, 2012–2019 ($MILLION)

128

U.S.: CLINICAL LABORATORY COAGULATION ANALYZERS MARKET SIZE, BY TYPE, 2012–2019 ($MILLION)

128

U.S.: COAGULATION INSTRUMENTS MARKET SIZE, BY TYPE, 2012–2019 ($MILLION)

129

TABLE 92

U.S.: CONSUMABLES MARKET SIZE, BY TYPE, 2012–2019 ($MILLION)

129

TABLE 93

U.S.: COAGULATION ANALYZERS MARKET SIZE, BY TYPE OF TEST, 2012–2019 ($MILLION)

130

U.S.: COAGULATION ANALYZERS MARKET SIZE, BY END USER, 2012–2019 ($MILLION)

130

CANADA: COAGULATION ANALYZERS MARKET SIZE, BY PRODUCT, 2012–2019 ($MILLION)

132

CANADA: CLINICAL LABORATORY COAGULATION ANALYZERS MARKET SIZE, BY TYPE, 2012–2019 ($MILLION)

132

CANADA: COAGULATION INSTRUMENTS MARKET SIZE, BY TYPE, 2012–2019 ($MILLION)

132

TABLE 98

CANADA: CONSUMABLES MARKET SIZE, BY TYPE, 2012–2019 ($MILLION)

133

TABLE 99

CANADA: COAGULATION ANALYZERS MARKET SIZE, BY TYPE OF TEST, 2012–2019 ($MILLION)

133

CANADA: COAGULATION ANALYZERS MARKET SIZE, BY END USER, 2012–2019 ($MILLION)

134

EUROPE: COAGULATION ANALYZERS MARKET SIZE, BY PRODUCT, 2012–2019 ($MILLION)

136

EUROPE: CLINICAL LABORATORY COAGULATION ANALYZERS MARKET SIZE, BY TYPE, 2012–2019 ($MILLION)

136

EUROPE: COAGULATION INSTRUMENTS MARKET SIZE, BY TYPE, 2012–2019 ($MILLION)

137

TABLE 104

EUROPE: CONSUMABLES MARKET SIZE, BY TYPE, 2012–2019 ($MILLION)

137

TABLE 105

EUROPE: COAGULATION ANALYZERS MARKET SIZE, BY TYPE OF TEST, 2012–2019 ($MILLION)

137

EUROPE: COAGULATION ANALYZERS MARKET SIZE, BY END USER, 2012–2019 ($MILLION)

138

GERMANY: COAGULATION ANALYZERS MARKET SIZE, BY PRODUCT, 2012–2019 ($MILLION)

139

GERMANY: CLINICAL LABORATORY COAGULATION ANALYZERS MARKET SIZE, BY TYPE, 2012–2019 ($MILLION)

140

GERMANY: COAGULATION INSTRUMENTS MARKET SIZE, BY TYPE, 2012–2019 ($MILLION)

140

GERMANY: CONSUMABLES MARKET SIZE, BY TYPE, 2012–2019 ($MILLION)

141

TABLE 84 TABLE 85

TABLE 88 TABLE 89 TABLE 90 TABLE 91

TABLE 94 TABLE 95 TABLE 96 TABLE 97

TABLE 100 TABLE 101 TABLE 102 TABLE 103

TABLE 106 TABLE 107 TABLE 108 TABLE 109 TABLE 110

22 © MarketsandMarkets

Coagulation/Hemostasis Analyzer Market – Forecast to 2019

TABLE 111

MD 3255

GERMANY: COAGULATION ANALYZERS MARKET SIZE, BY TYPE OF TEST, 2012– 2019 ($MILLION)

141

GERMANY: COAGULATION ANALYZERS MARKET SIZE, BY END USER, 2012–2019 ($MILLION)

142

FRANCE: COAGULATION ANALYZERS MARKET SIZE, BY PRODUCT, 2012–2019 ($MILLION)

143

FRANCE: CLINICAL LABORATORY COAGULATION ANALYZERS MARKET SIZE, BY TYPE, 2012–2019 ($MILLION)

143

FRANCE: COAGULATION INSTRUMENTS MARKET SIZE, BY TYPE, 2012–2019 ($MILLION)

144

TABLE 116

FRANCE: CONSUMABLES MARKET SIZE, BY TYPE, 2012–2019 ($MILLION)

144

TABLE 117

FRANCE: COAGULATION ANALYZERS MARKET SIZE, BY TYPE OF TEST, 2012–2019 ($MILLION)

144

FRANCE: COAGULATION ANALYZERS MARKET SIZE, BY END USER, 2012–2019 ($MILLION)

145

U.K.: COAGULATION ANALYZERS MARKET SIZE, BY PRODUCT, 2012–2019 ($MILLION)

146

U.K.: CLINICAL LABORATORY COAGULATION ANALYZERS MARKET SIZE, BY TYPE, 2012–2019 ($MILLION)

146

U.K.: COAGULATION INSTRUMENTS MARKET SIZE, BY TYPE, 2012–2019 ($MILLION)

147

TABLE 122

U.K.: CONSUMABLES MARKET SIZE, BY TYPE, 2012–2019 ($MILLION)

147

TABLE 123

U.K.: COAGULATION ANALYZERS MARKET SIZE, BY TYPE OF TEST, 2012–2019 ($MILLION)

148

U.K.: COAGULATION ANALYZERS MARKET SIZE, BY END USER, 2012–2019 ($MILLION)

148

ITALY: COAGULATION ANALYZERS MARKET SIZE, BY PRODUCT, 2012–2019 ($MILLION)

149

ITALY: CLINICAL LABORATORY COAGULATION ANALYZERS MARKET SIZE, BY TYPE, 2012–2019 ($MILLION)

150

ITALY: COAGULATION INSTRUMENTS MARKET SIZE, BY TYPE, 2012–2019 ($MILLION)

150

TABLE 128

ITALY: CONSUMABLES MARKET SIZE, BY TYPE, 2012–2019 ($MILLION)

151

TABLE 129

ITALY: COAGULATION ANALYZERS MARKET SIZE, BY TYPE OF TEST, 2012–2019 ($MILLION)

151

ITALY: COAGULATION ANALYZERS MARKET SIZE, BY END USER, 2012–2019 ($MILLION)

152

SPAIN: COAGULATION ANALYZERS MARKET SIZE, BY PRODUCT, 2012–2019 ($MILLION)

153

SPAIN: CLINICAL LABORATORY COAGULATION ANALYZERS MARKET SIZE, BY TYPE, 2012–2019 ($MILLION)

153

SPAIN: COAGULATION INSTRUMENTS MARKET SIZE, BY TYPE, 2012–2019 ($MILLION)

154

TABLE 134

SPAIN: CONSUMABLES MARKET SIZE, BY TYPE, 2012–2019 ($MILLION)

154

TABLE 135

SPAIN: COAGULATION ANALYZERS MARKET SIZE, BY TYPE OF TEST, 2012–2019 ($MILLION)

155

SPAIN: COAGULATION ANALYZERS MARKET SIZE, BY END USER, 2012–2019 ($MILLION)

155

ROE: COAGULATION ANALYZERS MARKET SIZE, BY PRODUCT, 2012–2019 ($MILLION)

156

TABLE 112 TABLE 113 TABLE 114 TABLE 115

TABLE 118 TABLE 119 TABLE 120 TABLE 121

TABLE 124 TABLE 125 TABLE 126 TABLE 127

TABLE 130 TABLE 131 TABLE 132 TABLE 133

TABLE 136 TABLE 137

23 © MarketsandMarkets

Coagulation/Hemostasis Analyzer Market – Forecast to 2019

TABLE 138

MD 3255

ROE: CLINICAL LABORATORY COAGULATION ANALYZERS MARKET SIZE, BY TYPE, 2012–2019 ($MILLION)

157

ROE: COAGULATION INSTRUMENTS MARKET SIZE, BY TYPE, 2012–2019 ($MILLION)

157

TABLE 140

ROE: CONSUMABLES MARKET SIZE, BY TYPE, 2012–2019 ($MILLION)

158

TABLE 141

ROE: COAGULATION ANALYZERS MARKET SIZE, BY TYPE OF TEST, 2012–2019 ($MILLION)

158

ROE: COAGULATION ANALYZERS MARKET SIZE, BY END USER, 2012–2019 ($MILLION)

159

ASIA-PACIFIC: COAGULATION ANALYZERS MARKET SIZE, BY PRODUCT, 2012–2019 ($MILLION)

160

ASIA-PACIFIC: CLINICAL LABORATORY COAGULATION ANALYZERS MARKET SIZE, BY TYPE, 2012–2019 ($MILLION)

161

ASIA-PACIFIC: COAGULATION INSTRUMENTS MARKET SIZE, BY TYPE, 2012–2019 ($MILLION)

161

TABLE 146

ASIA-PACIFIC: CONSUMABLES MARKET SIZE, BY TYPE, 2012–2019 ($MILLION)

162

TABLE 147

ASIA-PACIFIC: COAGULATION ANALYZERS MARKET SIZE, BY TYPE OF TEST, 2012– 2019 ($MILLION)

162

ASIA-PACIFIC: COAGULATION ANALYZERS MARKET SIZE, BY END USER, 2012– 2019 ($MILLION)

163

JAPAN: COAGULATION ANALYZERS MARKET SIZE, BY PRODUCT, 2012–2019 ($MILLION)

164

JAPAN: CLINICAL LABORATORY COAGULATION ANALYZERS MARKET SIZE, BY TYPE, 2012–2019 ($MILLION)

164

JAPAN: COAGULATION INSTRUMENTS MARKET SIZE, BY TYPE, 2012–2019 ($MILLION)

164

TABLE 152

JAPAN: CONSUMABLES MARKET SIZE, BY TYPE, 2012–2019 ($MILLION)

165

TABLE 153

JAPAN: COAGULATION ANALYZERS MARKET SIZE, BY TYPE OF TEST, 2012–2019 ($MILLION)

165

JAPAN: COAGULATION ANALYZERS MARKET SIZE, BY END USER, 2012–2019 ($MILLION)

166

CHINA: COAGULATION ANALYZERS MARKET SIZE, BY PRODUCT, 2012–2019 ($MILLION)

167

CHINA: CLINICAL LABORATORY COAGULATION ANALYZERS MARKET SIZE, BY TYPE, 2012–2019 ($MILLION)

168

CHINA: COAGULATION INSTRUMENTS MARKET SIZE, BY TYPE, 2012–2019 ($MILLION)

168

TABLE 158

CHINA: CONSUMABLES MARKET SIZE, BY TYPE, 2012–2019 ($MILLION)

169

TABLE 159

CHINA: COAGULATION ANALYZERS MARKET SIZE, BY TYPE OF TEST, 2012–2019 ($MILLION)

169

CHINA: COAGULATION ANALYZERS MARKET SIZE, BY END USER, 2012–2019 ($MILLION)

170

INDIA: COAGULATION ANALYZERS MARKET SIZE, BY PRODUCT, 2012–2019 ($MILLION)

172

INDIA: CLINICAL LABORATORY COAGULATION ANALYZERS MARKET SIZE, BY TYPE, 2012–2019 ($MILLION)

172

INDIA: COAGULATION INSTRUMENTS MARKET SIZE, BY TYPE, 2012–2019 ($MILLION)

173

TABLE 164

INDIA: CONSUMABLES MARKET SIZE, BY TYPE, 2012–2019 ($MILLION)

173

TABLE 165

INDIA: COAGULATION ANALYZERS MARKET SIZE, BY TYPE OF TEST, 2012–2019 ($MILLION)

174

TABLE 139

TABLE 142 TABLE 143 TABLE 144 TABLE 145

TABLE 148 TABLE 149 TABLE 150 TABLE 151

TABLE 154 TABLE 155 TABLE 156 TABLE 157

TABLE 160 TABLE 161 TABLE 162 TABLE 163

24 © MarketsandMarkets

Coagulation/Hemostasis Analyzer Market – Forecast to 2019

TABLE 166

MD 3255

INDIA: COAGULATION ANALYZERS MARKET SIZE, BY END USER, 2012–2019 ($MILLION)

174

ROAPAC: COAGULATION ANALYZERS MARKET SIZE, BY PRODUCT, 2012–2019 ($MILLION)

175

ROAPAC: CLINICAL LABORATORY COAGULATION ANALYZERS MARKET SIZE, BY TYPE, 2012–2019 ($MILLION)

176

ROAPAC: COAGULATION INSTRUMENTS MARKET SIZE, BY TYPE, 2012–2019 ($MILLION)

176

TABLE 170

ROAPAC: CONSUMABLES MARKET SIZE, BY TYPE, 2012–2019 ($MILLION)

177

TABLE 171

ROAPAC: COAGULATION ANALYZERS MARKET SIZE, BY TYPE OF TEST, 2012–2019 ($MILLION)

177

ROA: COAGULATION ANALYZERS MARKET SIZE, BY END USER, 2012–2019 ($MILLION)

178

ROW: COAGULATION ANALYZERS MARKET SIZE, BY PRODUCT, 2012–2019 ($MILLION)

180

ROW: CLINICAL LABORATORY COAGULATION ANALYZERS MARKET SIZE, BY TYPE, 2012–2019 ($MILLION)

180

ROW: COAGULATION INSTRUMENTS MARKET SIZE, BY TYPE, 2012–2019 ($MILLION)

181

TABLE 176

ROW: CONSUMABLES MARKET SIZE, BY TYPE, 2012–2019 ($MILLION)

181

TABLE 177

ROW: COAGULATION ANALYZERS MARKET SIZE, BY TYPE OF TEST, 2012–2019 ($MILLION)

182

ROW: COAGULATION ANALYZERS MARKET SIZE, BY END USER, 2012–2019 ($MILLION)

182

TABLE 179

RECENT EXPANSION, 2012–2015

188

TABLE 180

RECENT NEW PRODUCT LAUNCHES, 2012–2015

189

TABLE 181

RECENT AGREEMENTS, PARTNERSHIPS, & COLLABORATIONS, 2012–2015

190

TABLE 182

RECENT ACQUISITIONS, 2012-2015

191

TABLE 183

RECENT OTHER DEVELOPMENTS, 2014

191

TABLE 167 TABLE 168 TABLE 169

TABLE 172 TABLE 173 TABLE 174 TABLE 175

TABLE 178

25 © MarketsandMarkets

Coagulation/Hemostasis Analyzer Market – Forecast to 2019

MD 3255

LIST OF FIGURES FIGURE 1

COAGULATION ANALYZERS MARKET, BY PRODUCT

18

FIGURE 2

RESEARCH DESIGN

22

FIGURE 3

TOP-DOWN APPROACH

23

FIGURE 4

BOTTOM-UP APPROACH

24

FIGURE 5

BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND REGION

25

FIGURE 6

DATA TRIANGULATION METHODOLOGY

25

FIGURE 7

NORTH AMERICA TO DOMINATE THE COAGULATION ANALYZERS MARKET

30

FIGURE 8

STANDALONE HOSPITALS SEGMENT WILL BE THE LARGEST END-USER SEGMENT IN THE COAGULATION ANALYZERS MARKET

32

FIGURE 9

COAGULATION ANALYZERS MARKET, BY GEOGRAPHY, 2014

32

FIGURE 10

POINT-OF-CARE TESTING ANALYZERS SEGMENT TO GROW AT THE HIGHEST CAGR

35

FIGURE 11

CONSUMABLES SEGMENT HELD THE LARGEST MARKET SHARE IN 2014

36

FIGURE 12

U.S. COMMANDS THE LARGEST SHARE OF THE MARKET

37

FIGURE 13

FULLY AUTOMATED ANALYZERS SEGMENT DOMINATES MARKET

38

FIGURE 14

PT/INR SEGMENT DOMINATES THE MARKET

39

FIGURE 15

STANDALONE HOSPITALS WILL CONTINUE TO LEAD THE COAGULATION ANALYZERS END-USERS MARKET DURING THE FORECAST PERIOD

40

FIGURE 16

ASIA TO WITNESS HIGH GROWTH DURING FORECAST PERIOD

41

FIGURE 17

COAGULATION ANALYZERS MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES

46

FIGURE 18

PORTER’S FIVE FORCES ANALYSIS

54

FIGURE 19

SUPPLY CHAIN ANALYSIS

57

FIGURE 20

STRATEGIC BENCHMARKING: SYSMEX CORPORATION LARGELY ADOPTED ORGANIC GROWTH STRATEGIES TO ENHANCE ITS PRODUCT OFFERINGS

59

PT/INR SEGMENT WILL CONTINUE TO DOMINATE THE COAGULATION ANALYZERS MARKET DURING THE FORECAST PERIOD

62

CONSUMABLES SEGMENT WILL DRIVE THE COAGULATION ANALYZERS MARKET DURING THE FORECAST PERIOD

78

FULLY AUTOMATED ANALYZERS SEGMENT IS THE FASTEST-GROWING SEGMENT DURING THE FORECAST PERIOD

81

ASIA IS THE FASTEST-GROWING REGION IN POINT-OF-CARE TESTING COAGULATION ANALYZERS MARKET DURING FORECAST PERIOD

97

PHOTO OPTICAL TECHNOLOGY ACCOUNTED FOR THE LARGEST SHARE OF THE COAGULATION ANALYZERS MARKET, BY TECHNOLOGY

102

THE STANDALONE HOSPITALS SEGMENT IS EXPECTED TO DRIVE THE GROWTH OF THE COAGULATION ANALYZERS MARKET IN THE FORECAST PERIOD

105

GEOGRAPHIC SNAPSHOT (2014): EMERGING MARKETS HOLD SIGNIFICANT GROWTH OPPORTUNITIES FOR COAGULATION ANALYZERS

118

THE CONSUMABLES SEGMENT WILL CONTINUE TO DRIVE THE COAGULATION ANALYZERS MARKET IN THE FORECAST PERIOD

119

INCREASING INVESTMENTS FOR THE DEVELOPMENT OF COAGULATION ANALYZERS ARE DRIVING MARKET GROWTH

123

GERMANY WILL CONTINUE TO DOMINATE THE EUROPEAN COAGULATION ANALYZERS MARKET IN THE FORECAST PERIOD

135

FIGURE 21 FIGURE 22 FIGURE 23 FIGURE 24 FIGURE 25 FIGURE 26 FIGURE 27 FIGURE 28 FIGURE 29 FIGURE 30

26 © MarketsandMarkets

Coagulation/Hemostasis Analyzer Market – Forecast to 2019

FIGURE 31 FIGURE 32 FIGURE 33 FIGURE 34 FIGURE 35 FIGURE 36 FIGURE 37 FIGURE 38

MD 3255

COAGULATION ANALYZERS MARKET IN ASIA-PACIFIC TO GROW AT THE HIGHEST CAGR

159

CLINICAL LABORATORY ANALYZERS MARKET IN INDIA HAS HIGH GROWTH POTENTIAL

171

THE CONSUMABLES SEGMENT WILL DOMINATE THE ROW CLINICAL LABORATORY ANALYZERS MARKET IN 2019

178

NEW PRODUCT LAUNCHES WAS THE PREFERRED STRATEGY FOR MAJOR PLAYERS IN THE COAGULATION ANALYZERS MARKET

184

GLOBAL CLINICAL LABORATORY ANALYZERS MARKET SHARE,

BY KEY PLAYER, 2014

185

GLOBAL POINT-OF-CARE COAGULATION ANALYZERS MARKET SHARE, BY KEY PLAYER, 2014

186

BATTLE FOR MARKET SHARE: EXPANSION WAS THE KEY STRATEGY ADOPTED BY MARKET PLAYERS

187

GEOGRAPHIC REVENUE MIX FOR TOP 3 MARKET PLAYERS

193

27 © MarketsandMarkets

Coagulation/Hemostasis Analyzer Market – Forecast to 2019

MD 3255

SAMPLE TABLES TABLE 1

EUROPE: COAGULATION ANALYZERS MARKET SIZE FOR STANDALONE HOSPITALS,

BY COUNTRY, 2012–2019 ($MILLION) Country

2012

2013

2014-e

2019-p

CAGR% (2014–2019)

Germany

XX

XX

XX

XX

XX

France

XX

XX

XX

XX

XX

U.K.

XX

XX

XX

XX

XX

Italy

XX

XX

XX

XX

XX

Spain

XX

XX

XX

XX

XX

Rest of Europe

XX

XX

XX

XX

XX

Total

XX

XX

XX

XX

XX

e – Estimated; p – Projected Source: Annual Reports, SEC Filings, Press Releases, Investor Presentations, World Health Organization (WHO), Centers for Disease Control and Prevention (CDC), American Society for Clinical Pathology (ASCP), American Association for Clinical Chemistry (AACC), USChina Point of Care Testing (POCT) Forum, Asian-Pacific Society of Thrombosis and Hemostasis (APSTH), U.S. Department of Health & Human Services (HHS), International Society on Thrombosis and Haemostasis (ISTH), Canadian Institute for Health Information (CIHI), American Thrombosis and Hemostasis Network (ATHN), Foundation for Innovative New Diagnostics(FIND), National Health Service (NHS), Expert Interviews, and MarketsandMarkets Analysis

Germany commanded the largest share of XX% of the European coagulation analyzers market for standalone hospitals in 2014. This segment is poised to reach $XX million by 2019 from $XX million in 2014, at a CAGR of XX% from 2014 to 2019.

TABLE 2

NORTH AMERICA: COAGULATION ANALYZERS MARKET SIZE FOR OTHERS, BY COUNTRY, 2012–2019 ($MILLION) Country

2012

2013

2014-e

2019-p

CAGR% (2014–2019)

U.S.

XX

XX

XX

XX

XX

Canada

XX

XX

XX

XX

XX

Total

XX

XX

XX

XX

XX

e – Estimated; p – Projected Source: Annual Reports, SEC Filings, Press Releases, Investor Presentations, World Health Organization (WHO), Centers for Disease Control and Prevention (CDC), American Society for Clinical Pathology (ASCP), American Association for Clinical Chemistry (AACC), USChina Point of Care Testing (POCT) Forum, Asian-Pacific Society of Thrombosis and Hemostasis (APSTH), U.S. Department of Health & Human Services (HHS), International Society on Thrombosis and Haemostasis (ISTH), Canadian Institute for Health Information (CIHI), American Thrombosis and Hemostasis Network (ATHN), Foundation for Innovative New Diagnostics(FIND), National Health Service (NHS), Expert Interviews, and MarketsandMarkets Analysis

The U.S. commanded the largest share of XX% of the North American coagulation analyzers market for others in 2014. This segment is poised to reach $XX million by 2019 from $XX million in 2014, at a CAGR of XX% from 2014 to 2019.

28 © MarketsandMarkets

Coagulation/Hemostasis Analyzer Market – Forecast to 2019

TABLE 3

MD 3255

NORTH AMERICA: COAGULATION ANALYZERS MARKET SIZE, BY COUNTRY, 2012–2019 ($MILLION) Country

2012

2013

2014-e

CAGR% (2014–2019)

2019-p

U.S.

XX

XX

XX

XX

XX

Canada

XX

XX

XX

XX

XX

Total

XX

XX

XX

XX

XX

Source: Annual Reports, SEC Filings, Press Releases, Investor Presentations, World Health Organization (WHO), Centers for Disease Control and Prevention (CDC), American Society for Clinical Pathology (ASCP), American Association for Clinical Chemistry (AACC), USChina Point of Care Testing (POCT) Forum, Asian-Pacific Society of Thrombosis and Hemostasis (APSTH), U.S. Department of Health & Human Services (HHS), International Society on Thrombosis and Haemostasis (ISTH), Canadian Institute for Health Information (CIHI), American Thrombosis and Hemostasis Network (ATHN), Foundation for Innovative New Diagnostics(FIND), National Health Service (NHS), Expert Interviews, and MarketsandMarkets Analysis

The U.S. commanded the largest share of XX% of the North American coagulation analyzers market in 2014. It is poised to reach $XX million by 2019 from $XX million in 2014, at a CAGR of XX% from 2014 to 2019.

29 © MarketsandMarkets

Coagulation/Hemostasis Analyzer Market – Forecast to 2019

MD 3255

RELATED REPORTS Report Title

Published Date

Hematology Analyzers & Reagents Market 1

by Products (3-& 5- part hematology Analyzers, Point-of-Care, & Fully Automated), Consumables (Reagents & Stains), End Users (Research Institute, Hospital, & Clinical Testing Labs) - Global Forecasts to 2019

May 2014

http://www.marketsandmarkets.com/Market-Reports/hematology-analyzers-reagentsmarket-153222146.html

In Vitro Diagnostic (IVD) Market 2

[Instruments, Reagents & Data Management Systems] [Technique (Immunoassay, Clinical Chemistry, Molecular Diagnostics, Haematology) & Applications (Diabetes, Infectious Diseases, Cancer & Cardiology)] Systems, End Users] – Forecast To 2017

July 2013

http://www.marketsandmarkets.com/Market-Reports/ivd-in-vitro-diagnostics-market703.html

Point-Of-Care Diagnostics / Testing Market 3

by Products (Glucose Monitoring & Infectious Diseases Testing Kits, Cardiac & Tumor Markers), by End Users (Self & Professional Monitoring), Over the Counter & Prescription Based - Global Forecast to 2018

September 2014

http://www.marketsandmarkets.com/Market-Reports/point-of-care-diagnostic-market106829185.html

30 © MarketsandMarkets

Coagulation/Hemostasis Analyzer Market â&#x20AC;&#x201C; Forecast to 2019

MD 3255

Disclaimer: MarketsandMarkets strategic analysis services are limited publications containing valuable market information provided to a select group of customers in response to orders. Our customers acknowledge, when ordering, that MarketsandMarkets strategic analysis services are for our customersâ&#x20AC;&#x2122; internal use and not for general publication or disclosure to third parties. Quantitative market information is based primarily on interviews and therefore, is subject to fluctuation.

MarketsandMarkets does not endorse any vendor, product or service depicted in its research publications.

MarketsandMarkets strategic analysis publications consist of the opinions of MarketsandMarkets' research and should not be construed as statements of fact. MarketsandMarkets disclaims all warranties, expressed or implied, with respect to this research, including any warranties of merchantability or fitness for a particular purpose.

MarketsandMarkets takes no responsibility for any incorrect information supplied to us by manufacturers or users.

All trademarks, copyrights and other forms of intellectual property belong to their respective owners and may be protected by copyright. Under no circumstance may any of these be reproduced in any form without the prior written agreement of their owner.

No part of this strategic analysis service may be given, lent, resold or disclosed to non-customers without written permission.

Reproduction and/or transmission in any form and by any means including photocopying, mechanical, electronic, recording or otherwise, without the permission of the publisher is prohibited.

For information regarding permission, contact: Tel: 1-888-600-6441 Email: sales@marketsandmarkets.com

31 Š MarketsandMarkets